HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann Mosher Selected Research

rifapentine (Priftin)

6/2002A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann Mosher Research Topics

Disease

2Latent Tuberculosis
01/2012 - 06/2002
2Tuberculosis (Tuberculoses)
05/2011 - 06/2002
1Infections
05/2011
1Latent Infection
05/2011

Drug/Important Bio-Agent (IBA)

1AntigensIBA
05/2011
1Biomarkers (Surrogate Marker)IBA
05/2011
1Rifampin (Rifampicin)FDA LinkGeneric
06/2002
1Isoniazid (Ftivazide)FDA LinkGeneric
06/2002
1rifapentine (Priftin)FDA Link
06/2002

Therapy/Procedure

1Therapeutics
01/2012